Pittcon announced that Alan G. Marshall, Kasha Professor of Chemistry and Biochemistry at Florida State University (Tallahassee, Florida) and director of the Ion Cyclotron Resonance Program at the National High Magnetic Field Laboratory, will be the plenary lecturer during the opening session on March 1 at Pittcon 2010.
Pittcon (Pittsburgh, Pennsylvania) announced that Alan G. Marshall, Kasha Professor of Chemistry and Biochemistry at Florida State University (Tallahassee, Florida) and director of the Ion Cyclotron Resonance Program at the National High Magnetic Field Laboratory will be the plenary lecturer during the opening session on March 1 at Pittcon 2010.
The conference will be held February 28 to March 5, 2010, in Orlando, Florida, at the Orange County Convention Center, West Building. Marshall’s presentation will focus on how high-end instrumentation has both advanced state-of-the-art applications and stimulated the performance of lower-end instrumentation. He will present examples drawn from cyclotrons, lasers, mass spectrometry, microscopy, NMR spectroscopy, Raman spectroscopy, and robots.
Marshall co-invented and continues to lead in the development of Fourier-transform ion cyclotron resonance mass spectrometry. His current research includes instrumentation development, fossil fuels and environmental analysis, and mapping the primary and higher-order structures of biological macromolecules and their complexes.
AI Boosts SERS for Next Generation Biomedical Breakthroughs
July 2nd 2025Researchers from Shanghai Jiao Tong University are harnessing artificial intelligence to elevate surface-enhanced Raman spectroscopy (SERS) for highly sensitive, multiplexed biomedical analysis, enabling faster diagnostics, imaging, and personalized treatments.
Machine Learning and Optical Spectroscopy Advance CNS Tumor Diagnostics
July 1st 2025A new review article highlights how researchers in Moscow are integrating machine learning with optical spectroscopy techniques to enhance real-time diagnosis and surgical precision in central nervous system tumor treatment.